TM editors’ note: This article discusses a penny stock and/or microcap. Such stocks are easily manipulated; do your own careful due diligence.

CVR Medical (CRRVF) (TSX-V:CVM) is a medical device company whose primary product, the Carotid Stenotic Scan (CSS), is on track for FDA market clearance. The device uses patent-protected science to detect ischemia of the carotid artery, a direct risk factor for ischemic stroke. In what the company calls “game-changing technology,” the CSS is able to identify blockage within the arterial system and arm the clinician with the information necessary to potentially deter catastrophic events such as stroke in the future.

Technology

CVR’s Carotid Stenotic Scan utilizes patented subsonic sound analysis to determine the presence of arterial disease/blockage in the patient by analyzing the link between fluid flow and subsonic frequencies. More specifically, the device analyzes and takes into consideration the low frequency vibrations that radiate from the carotid arteries. When the blood is flowing through the arteries there is a production of wave patterns. These wave patterns are read by the machine and mathematically analyzed through CVR’s patented algorithm. This algorithm then determines an accurate percentage of stenosis with a range. This allows the immediate interpretation by doctors of what’s happening inside the arteries.

Opportunity

While new science and new technology is always what gets people excited, it’s the pragmatics that often ultimately dictate success or failure. As company COO/EVP Tony Robinson told us,

Currently, there are other devices on the market which can detect this disease, but none which can act as a cost-effective tool to detect this presence early on when actions can be taken to prevent the negative outcomes. The CSS will empower the Primary Care Physician with the information necessary to either implement the proper treatment themselves, or refer onto a cardiovascular specialist. The overall goal is to not rival other modalities on the market, but instead streamline the process and ensure that the patients who most need medical care are able to receive it.